USPTO 2015–2025 USPTO PatentsView Foreign Corporation

medmix Switzerland AG

USPTO PatentsView assignee record - 50 granted patents across 23 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B05C (Apparatus FOR Applying Fluent Materials TO Surfaces, IN General).

RSS updates for this company

The verdict

According to USPTO PatentsView, medmix ranks #6,677 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 23 technology areas.

#6,677
of 49,997 US assignees by volume
Top 3%
by Innovation Score (60.6/100)
16.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R6677 · Foreign Corporation #6,677 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 50 grants
  • UPPER-Q #6,677/49,997
  • PHOTO-FINISH inMusic Brands
  • CPC-FOCUS B05C · 23 areas
  • INNOV-STRONG 60.6/100
  • CLAIMS-RICH 16.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: inMusic Brands, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around medmix

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows medmix's Innovation Score is 60.6/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where medmix's grants concentrate

medmix Switzerland AG is a focused PatentsView assignee: 23 CPC subclasses with 44% of grants classified under B05C (Apparatus FOR Applying Fluent Materials TO Surfaces, IN General). Peak complete grant year is 2024 (20 grants) versus a trough of 10 in 2022. By volume, medmix sits between Wenzhou University and Agfa Graphics NV.

medmix's three-year grant acceleration

medmix Switzerland AG shows 41 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at medmix's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows medmix holds 50 patents at rank #6,729, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near medmix

By rank, the assignees closest to #6,729 in granted patent volume.

Leaders in B05C (Apparatus FOR Applying Fluent Materials TO Surfaces)

Other assignees with the most granted patents in medmix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for medmix, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (61 here).

Similar claim depth

Nearest assignees by average claims per patent (16.7 here).

medmix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

510152025 2022202320242025 9
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
medmix Switzerland AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 10 20.0%
2023 11 22.0%
2024 20 40.0%
2025partial year 9 18.0%

Which technologies does medmix Switzerland AG patent most?

Top 15 of 23 technology areas

Where it ranks

Overall rank by patents

#6,677

of 49,997 tracked assignees

Innovation Score

60.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

medmix Switzerland AG's patent record in context - here's where to go next.

  • medmix Switzerland AG's lead technology class is B05C (Apparatus FOR Applying Fluent Materials TO Surfaces, IN General), 44% of its portfolio - see every assignee active in that class. Explore B05C
  • Ranked #6,677 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare medmix Switzerland AG against Wenzhou University, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 60.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.